Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis

Urinary levels of monocyte chemoattractant protein (MCP)‐1 and disease activity in patients with IgA nephropathy

Akemi Saitoh 1, Yusuke Suzuki 1, Masahiro Takeda 1, Kiichi Kubota 2, Kiichi Itoh 3, Yasuhiko Tomino 1,
PMCID: PMC6808122  PMID: 9484662

Abstract

Using a quantitative sandwich ELISA, we studied 17 patients with IgA nephropathy to determine if levels of urinary monocyte chemoattractant protein‐1 (MCP‐1) might reflect the disease activity. The levels of urinary MCP‐1 in patients with the advanced stage were significantly higher than those in patients with the mild stage of the disease, or in healthy controls. The results showed a significant correlation between the levels of urinary MCP‐1 and the disease activity, i.e., levels of urinary casts and urinary protein. It was thus suggested that the measurement of urinary MCP‐1 is useful in evaluating the degree of renal injuries and/or prognosis in patients with IgA nephropathy. J. Clin. Lab. Anal. 12:1–5, 1998. © 1998 Wiley‐Liss, Inc.

Keywords: MCP‐1, ELISA, urine, renal histology, IgA nephropathy

References

  • 1. Berger J, Hinglasis N: Les depǒts intércapillaires d'IgA‐IgG. J Urol Nephrol 74: 694–695, 1968. [PubMed] [Google Scholar]
  • 2. Tomino Y: The future: A Japanese perspective In: IgA Nephropathy. Clarkson AR, ed. Nijhoff, Boston, 1987, p 225–233. [Google Scholar]
  • 3. Brentjens JR, Sepulveda M, Baliah T, Bentzel C, Erlanger BF, Elwood C, Montes M, Hsu KC, Andres GA: Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int 7: 342–350, 1975. [DOI] [PubMed] [Google Scholar]
  • 4. Tomino Y, Ozaki T, Koide H, Takahashi M, Ito K: Serum levels of interleukin‐2 receptor and disease activity in patients with IgA nephropathy. J Clin Lab Anal 3: 355–359, 1989. [DOI] [PubMed] [Google Scholar]
  • 5. Tomino Y, Funabiki K, Ohmuro H, Shimizu M, Yokoyama K, Shirato I, Shirai T, Takahashi M, Koide H: Urinary interleukin‐6 and disease activity in patients with IgA nephropathy. Am J Nephrol 11: 459–464, 1991. [DOI] [PubMed] [Google Scholar]
  • 6. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D: Increased expression of monocyte chemoattractant protein‐1 in antithymocyte antibody‐induced glomerulonephritis. Kidney Int 44: 1036–1047, 1993. [DOI] [PubMed] [Google Scholar]
  • 7. Baggiolini M, Dewald B, Moser B: Interleukin‐8 and related chemotactic cytokines CXC and CC chemokines. Adv Immunol 55: 97–179, 1994. [PubMed] [Google Scholar]
  • 8. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenhaim JJ, Larsen CG, Zachariae CC, Matsushima K: Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL‐1 and TNF. J Immunol 144: 3034–3038, 1990. [PubMed] [Google Scholar]
  • 9. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlondorff D: Regulation of monocyte chemoattractant protein‐1 and macrophage colony‐stimulating factor‐1 by IFNγ, tumor necrosis factor‐α, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150: 1971–1979, 1993. [PubMed] [Google Scholar]
  • 10. Carr WM, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein‐1 acts as a T‐lymphocyte chemoattractant. Proc Natl Acad Sci USA 91: 3652–3656, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim JJ: Monocyte chemotactic for human T lymphocytes. J Clin Invest 95: 1370–1376, 1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A: Monocyte chemoattractant protein‐1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 73: 804–809, 1995. [PubMed] [Google Scholar]
  • 13. Tomino Y, Sakai H, Endoh M, Kaneshige H, Nomoto Y: Detection of immune complexes in polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Clin Immunol Immunopathol 24: 63–71, 1982. [DOI] [PubMed] [Google Scholar]
  • 14. . QuantikineTM Human MCP‐1 Immunoassay, Catalog Number DCP00, R & D systems, Minneapolis, MN 55413.
  • 15. Jiang Y, Seller DI, Frendl G, Graves DT: Monocyte chemoattractant protein‐1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 148: 2423–2428, 1992. [PubMed] [Google Scholar]
  • 16. Tomino Y, Ohmuro H, Kuramoto T, Shirato I, Eguchi K, Sakai H, Okumura K, Koide H: Expression of intercellular adhesion molecule‐1 and infiltration of lymphocytes in glomeruli of patients with IgA nephropathy. Nephron 67: 302–307, 1994. [DOI] [PubMed] [Google Scholar]
  • 17. Rovin BH, Rumanick M, Tan L, Dickerson J: Glomerular expression of monocyte chemoattractant protein‐1 in experimental and human glomerulonephritis. Lab Invest 71: 536–542, 1994. [PubMed] [Google Scholar]
  • 18. Prodjosudjadi W, Gerritsma JSL, van Es LA, Daha MR, Bruijn JA: Monocyte chemoattractant protein‐1 in normal and diseased human kidneys: An immunohistochemical analysis. Clin Nephrol 44: 148–155, 1995. [PubMed] [Google Scholar]
  • 19. Grandaliano G, Gesuldo L, Ranieri E, Monno R, Montinaro V, Marra F, Schena P: Monocyte chemotactic peptide‐1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 7: 906–913, 1996. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES